Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment ...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Dec 29, 2025-- Johnson & Johnson (NYSE: JNJ) (the “Company”) today announced the successful completion of its acquisition of Halda Therapeutics OpCo, Inc. (“Halda”), a clinical-stage biotechnology company with a …